Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine

Several reports of second malignant neoplasm (SMN) in patients with relapsed neuroblastoma after treatment with (131)I-MIBG suggest the possibility of increased risk. Incidence of and risk factors for SMN after (131)I-MIBG have not been defined. This is a multi-institutional retrospective review of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Cancer
Autors principals: Huibregtse, Kelly E., Vo, Kieuhoa T., DuBois, Steven G., Fetzko, Stephanie, Neuhaus, John, Batra, Vandana, Maris, John M., Weiss, Brian, Marachelian, Araz, Yanik, Greg A., Matthay, Katherine K.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523915/
https://ncbi.nlm.nih.gov/pubmed/27573428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.07.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars